U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 479

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:60948809-61284302
GRCh38:
Chr11:61181337-61516830
See casesUncertain significance
(Sep 21, 2012)
no assertion criteria provided
2.
GRCh37:
Chr11:61177001-61588631
GRCh38:
Chr11:61409529-61821159
See casesLikely benign
(Nov 30, 2010)
no assertion criteria provided
3.
GRCh37:
Chr11:61197461
GRCh38:
Chr11:61429989
SDHAF2not providedBenign
(Jun 23, 2018)
criteria provided, single submitter
4.
GRCh37:
Chr11:61197569
GRCh38:
Chr11:61430097
SDHAF2not specifiedLikely benign
(Nov 24, 2017)
criteria provided, single submitter
5.
GRCh37:
Chr11:61197590
GRCh38:
Chr11:61430118
SDHAF2Hereditary pheochromocytoma-paragangliomaUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr11:61197608
GRCh38:
Chr11:61430136
SDHAF2not specifiedLikely benign
(Mar 20, 2017)
criteria provided, single submitter
7.
GRCh37:
Chr11:61197614
GRCh38:
Chr11:61430142
SDHAF2Hereditary cancer-predisposing syndromeUncertain significance
(Oct 15, 2021)
criteria provided, single submitter
8.
GRCh37:
Chr11:61197614
GRCh38:
Chr11:61430142
SDHAF2Hereditary cancer-predisposing syndromeUncertain significance
(Apr 26, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr11:61197618
GRCh38:
Chr11:61430146
SDHAF2Paragangliomas 2, Hereditary cancer-predisposing syndrome, not provided
Conflicting interpretations of pathogenicity
(Mar 20, 2023)
criteria provided, conflicting interpretations
10.
GRCh37:
Chr11:61197620
GRCh38:
Chr11:61430148
SDHAF2M1THereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaUncertain significance
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr11:61197621
GRCh38:
Chr11:61430149
SDHAF2M1IHereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaUncertain significance
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr11:61197622
GRCh38:
Chr11:61430150
SDHAF2A2SHereditary cancer-predisposing syndromeUncertain significance
(Dec 19, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr11:61197623
GRCh38:
Chr11:61430151
SDHAF2A2VHereditary pheochromocytoma-paragangliomaUncertain significance
(Feb 24, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr11:61197624
GRCh38:
Chr11:61430152
SDHAF2Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeLikely benign
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr11:61197624
GRCh38:
Chr11:61430152
SDHAF2Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndrome, not provided
Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr11:61197625
GRCh38:
Chr11:61430153
SDHAF2V3MHereditary cancer-predisposing syndromeUncertain significance
(Jun 13, 2019)
criteria provided, single submitter
17.
GRCh37:
Chr11:61197625
GRCh38:
Chr11:61430153
SDHAF2V3LHereditary cancer-predisposing syndrome, not provided, Hereditary pheochromocytoma-paraganglioma
Conflicting interpretations of pathogenicity
(Mar 7, 2023)
criteria provided, conflicting interpretations
18.
GRCh37:
Chr11:61197626
GRCh38:
Chr11:61430154
SDHAF2V3AHereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaUncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr11:61197627
GRCh38:
Chr11:61430155
SDHAF2Hereditary cancer-predisposing syndromeUncertain significance
(Dec 9, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr11:61197627
GRCh38:
Chr11:61430155
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Apr 20, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr11:61197627
GRCh38:
Chr11:61430155
SDHAF2Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaLikely benign
(Aug 15, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr11:61197628
GRCh38:
Chr11:61430156
SDHAF2S4AHereditary pheochromocytoma-paragangliomaUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
23.
GRCh37:
Chr11:61197629
GRCh38:
Chr11:61430157
SDHAF2S4FHereditary pheochromocytoma-paragangliomaUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr11:61197629
GRCh38:
Chr11:61430157
SDHAF2S4CHereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaUncertain significance
(Aug 6, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr11:61197630
GRCh38:
Chr11:61430158
SDHAF2Hereditary cancer-predisposing syndromeLikely benign
(May 26, 2019)
criteria provided, single submitter
26.
GRCh37:
Chr11:61197630
GRCh38:
Chr11:61430158
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Sep 3, 2020)
criteria provided, single submitter
27.
GRCh37:
Chr11:61197631
GRCh38:
Chr11:61430159
SDHAF2T5AHereditary cancer-predisposing syndrome, not provided, Hereditary pheochromocytoma-paraganglioma
Uncertain significance
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr11:61197632
GRCh38:
Chr11:61430160
SDHAF2T5IHereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaUncertain significance
(Aug 30, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr11:61197633
GRCh38:
Chr11:61430161
SDHAF2Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaBenign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr11:61197635
GRCh38:
Chr11:61430163
SDHAF2V6AHereditary pheochromocytoma-paragangliomaUncertain significance
(Oct 25, 2019)
criteria provided, single submitter
31.
GRCh37:
Chr11:61197636
GRCh38:
Chr11:61430164
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Apr 29, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr11:61197636
GRCh38:
Chr11:61430164
SDHAF2Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeLikely benign
(Sep 27, 2018)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr11:61197637
GRCh38:
Chr11:61430165
SDHAF2F7LHereditary pheochromocytoma-paragangliomaUncertain significance
(Mar 5, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr11:61197637
GRCh38:
Chr11:61430165
SDHAF2F7VHereditary pheochromocytoma-paragangliomaUncertain significance
(May 20, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr11:61197639
GRCh38:
Chr11:61430167
SDHAF2F7LHereditary pheochromocytoma-paragangliomaUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr11:61197639
GRCh38:
Chr11:61430167
SDHAF2Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeLikely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:61197640
GRCh38:
Chr11:61430168
SDHAF2S8PHereditary cancer-predisposing syndromeLikely benign
(Sep 26, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr11:61197640
GRCh38:
Chr11:61430168
SDHAF2S8THereditary cancer-predisposing syndromeUncertain significance
(May 7, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr11:61197641
GRCh38:
Chr11:61430169
SDHAF2S8WHereditary cancer-predisposing syndromeUncertain significance
(Feb 7, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr11:61197641
GRCh38:
Chr11:61430169
SDHAF2S8LHereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeUncertain significance
(Nov 27, 2021)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr11:61197641
GRCh38:
Chr11:61430169
SDHAF2S8*Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Aug 16, 2022)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr11:61197642
GRCh38:
Chr11:61430170
SDHAF2Hereditary cancer-predisposing syndromeLikely benign
(Jan 31, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr11:61197642
GRCh38:
Chr11:61430170
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Apr 15, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr11:61197642
GRCh38:
Chr11:61430170
SDHAF2Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeLikely benign
(Sep 3, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr11:61197643
GRCh38:
Chr11:61430171
SDHAF2T9AHereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaConflicting interpretations of pathogenicity
(Jun 10, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr11:61197644
GRCh38:
Chr11:61430172
SDHAF2T9IHereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeUncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr11:61197645
GRCh38:
Chr11:61430173
SDHAF2S10fsHereditary pheochromocytoma-paragangliomaPathogenic
(Aug 14, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr11:61197646
GRCh38:
Chr11:61430174
SDHAF2S10THereditary pheochromocytoma-paragangliomaUncertain significance
(Sep 2, 2021)
criteria provided, single submitter
49.
GRCh37:
Chr11:61197647
GRCh38:
Chr11:61430175
SDHAF2S10WHereditary cancer-predisposing syndromeUncertain significance
(Dec 24, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr11:61197647
GRCh38:
Chr11:61430175
SDHAF2S10fsHereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Mar 19, 2022)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr11:61197647
GRCh38:
Chr11:61430175
SDHAF2S10LHereditary pheochromocytoma-paragangliomaUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr11:61197648
GRCh38:
Chr11:61430176
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Dec 31, 2020)
criteria provided, single submitter
53.
GRCh37:
Chr11:61197650
GRCh38:
Chr11:61430178
SDHAF2S11*Hereditary pheochromocytoma-paragangliomaPathogenic
(Aug 25, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr11:61197650
GRCh38:
Chr11:61430178
SDHAF2S11WHereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 11, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr11:61197650
GRCh38:
Chr11:61430178
SDHAF2S11Lnot provided, Paragangliomas 2, Hereditary cancer-predisposing syndrome,
Hereditary pheochromocytoma-paraganglioma
Likely benign
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr11:61197651
GRCh38:
Chr11:61430179
SDHAF2Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaLikely benign
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr11:61197651
GRCh38:
Chr11:61430179
SDHAF2Hereditary cancer-predisposing syndromeLikely benign
(Oct 12, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr11:61197651
GRCh38:
Chr11:61430179
SDHAF2Hereditary cancer-predisposing syndromeUncertain significance
(Apr 18, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr11:61197652
GRCh38:
Chr11:61430180
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Nov 4, 2019)
criteria provided, single submitter
60.
GRCh37:
Chr11:61197653
GRCh38:
Chr11:61430181
SDHAF2L12QHereditary pheochromocytoma-paragangliomaUncertain significance
(Sep 15, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr11:61197653
GRCh38:
Chr11:61430181
SDHAF2L12PHereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaUncertain significance
(Nov 2, 2021)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr11:61197654
GRCh38:
Chr11:61430182
SDHAF2Hereditary pheochromocytoma-paragangliomaUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr11:61197655
GRCh38:
Chr11:61430183
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely pathogenic
(Jul 30, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr11:61197655
GRCh38:
Chr11:61430183
SDHAF2Hereditary cancer-predisposing syndromeUncertain significance
(Jul 7, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr11:61197659
GRCh38:
Chr11:61430187
SDHAF2Hereditary pheochromocytoma-paragangliomaUncertain significance
(Jun 13, 2020)
criteria provided, single submitter
66.
GRCh37:
Chr11:61197660
GRCh38:
Chr11:61430188
SDHAF2Hereditary pheochromocytoma-paragangliomaUncertain significance
(Feb 7, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr11:61197660-61197663
GRCh38:
Chr11:61430188-61430191
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Sep 1, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr11:61197661-61197663
GRCh38:
Chr11:61430189-61430191
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Jul 25, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr11:61197663
GRCh38:
Chr11:61430191
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Aug 22, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr11:61197664
GRCh38:
Chr11:61430192
SDHAF2Hereditary pheochromocytoma-paraganglioma, Paragangliomas 2, not specified
Benign/Likely benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr11:61197665
GRCh38:
Chr11:61430193
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Oct 17, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr11:61197666
GRCh38:
Chr11:61430194
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Sep 23, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr11:61197666
GRCh38:
Chr11:61430194
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Sep 5, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr11:61197668
GRCh38:
Chr11:61430196
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Apr 24, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr11:61197668
GRCh38:
Chr11:61430196
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Sep 15, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr11:61197670
GRCh38:
Chr11:61430198
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Jun 24, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr11:61197671
GRCh38:
Chr11:61430199
SDHAF2Hereditary pheochromocytoma-paraganglioma, not specifiedBenign/Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr11:61197673
GRCh38:
Chr11:61430201
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Oct 13, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr11:61197938
GRCh38:
Chr11:61430466
SDHAF2not providedLikely benign
(Jun 17, 2019)
criteria provided, single submitter
80.
GRCh37:
Chr11:61204921
GRCh38:
Chr11:61437449
SDHAF2not providedLikely benign
(Jun 23, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr11:61205077
GRCh38:
Chr11:61437605
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Sep 15, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr11:61205079
GRCh38:
Chr11:61437607
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Oct 5, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr11:61205087-61213553
GRCh38:
Chr11:61437615-61446081
SDHAF2Hereditary pheochromocytoma-paragangliomaUncertain significance
(Oct 30, 2019)
criteria provided, single submitter
84.
GRCh37:
Chr11:61205089
GRCh38:
Chr11:61437617
SDHAF2Hereditary pheochromocytoma-paragangliomaUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr11:61205090
GRCh38:
Chr11:61437618
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Jul 19, 2020)
criteria provided, single submitter
86.
GRCh37:
Chr11:61205091
GRCh38:
Chr11:61437619
SDHAF2Hereditary pheochromocytoma-paragangliomaLikely benign
(Jul 15, 2021)
criteria provided, single submitter
87.
GRCh37:
Chr11:61205092
GRCh38:
Chr11:61437620
SDHAF2Hereditary pheochromocytoma-paragangliomaUncertain significance
(Aug 8, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr11:61205095
GRCh38:
Chr11:61437623
SDHAF2Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaLikely pathogenic
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr11:61205096
GRCh38:
Chr11:61437624
SDHAF2Hereditary pheochromocytoma-paraganglioma, not provided, Hereditary cancer-predisposing syndrome,
Paragangliomas 2
Pathogenic/Likely pathogenic
(Dec 16, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr11:61205097
GRCh38:
Chr11:61437625
SDHAF2M13VHereditary pheochromocytoma-paragangliomaUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr11:61205097
GRCh38:
Chr11:61437625
SDHAF2M13LHereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paragangliomaUncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr11:61205098-61205101
GRCh38:
Chr11:61437626-61437629
SDHAF2A15fsParagangliomas 2Likely pathogenic
(Jan 1, 2019)
criteria provided, single submitter
93.
GRCh37:
Chr11:61205100
GRCh38:
Chr11:61437628
SDHAF2L14FHereditary pheochromocytoma-paragangliomaUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr11:61205103
GRCh38:
Chr11:61437631
SDHAF2A15PHereditary pheochromocytoma-paragangliomaUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr11:61205103
GRCh38:
Chr11:61437631
SDHAF2A15SHereditary pheochromocytoma-paragangliomaUncertain significance
(Aug 29, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr11:61205105
GRCh38:
Chr11:61437633
SDHAF2Hereditary cancer-predisposing syndromeLikely benign
(Nov 10, 2020)
criteria provided, single submitter
97.
GRCh37:
Chr11:61205106
GRCh38:
Chr11:61437634
SDHAF2L16VHereditary pheochromocytoma-paragangliomaUncertain significance
(Jul 22, 2019)
criteria provided, single submitter
98.
GRCh37:
Chr11:61205106
GRCh38:
Chr11:61437634
SDHAF2Hereditary pheochromocytoma-paraganglioma, Hereditary cancer-predisposing syndromeLikely benign
(Aug 3, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr11:61205108
GRCh38:
Chr11:61437636
SDHAF2Hereditary cancer-predisposing syndromeLikely benign
(Mar 13, 2020)
criteria provided, single submitter
100.
GRCh37:
Chr11:61205109
GRCh38:
Chr11:61437637
SDHAF2S17PHereditary cancer-predisposing syndromeUncertain significance
(Jul 22, 2020)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination